Investor · Waltham, MA

Kim Brazzell

Open Kim in the network graph →

Filings

5

SEC Form D

Connections

71

co-filers

Capital

$74.9M

across filings

Active

Jun 2015

to Jan 2017

Most-connected co-filers (71)

Howard B. Rosen · Hayward, CA5 shared Robert Paull · Boston, MA5 shared Mark J. Iwicki · Arlington, MA5 shared Robert Langer · PITTSBURGH, PA4 shared Robert Tepper · Newton, MA4 shared Kevin Bitterman · Cambridge, MA4 shared Charles B. Mcdermott · Waltham, MA4 shared Rajeev B. Shah · Waltham, MA4 shared Hongming B. Chen · Waltham, MA3 shared John P. Dubinsky · St. Louis, MO2 shared Ben A. Plotkin · St. Louis, MO2 shared Mark P. Fisher · St. Louis, MO2 shared James M. Zemlyak · St. Louis, MO2 shared Richard J. Himelfarb · St. Louis, MO2 shared W. D. Baker · SANTA MONICA, CA2 shared Lily D. Peng · Emeryville, CA2 shared Thomas W. Weisel · St. Louis, MO2 shared Bruce A. Beda · St. Louis, MO2 shared David D. Sliney · St. Louis, MO2 shared Kelvin R. Westbrook · St. Louis, MO2 shared Victor J. Nesi · St. Louis, MO2 shared Thomas P. Mulroy · St. Louis, MO2 shared Robert E. Grady · St. Louis, MO2 shared Aaron D. Mendelsohn · SANTA MONICA, CA2 shared

Recent filings (5)

Kala Pharmaceuticals, Inc.Nov 2021 · 27 co-filers$36.5M Kala Pharmaceuticals, Inc.Nov 2021 · 27 co-filers$36.5M STIFEL FINANCIAL CORPJan 2017 · 42 co-filers$9.4M Kala Pharmaceuticals, Inc.Apr 2016 · 28 co-filers$67.9M Kala Pharmaceuticals, Inc.Aug 2015 · 26 co-filers$7.0M STIFEL FINANCIAL CORPJun 2015 · 46 co-filers$73.2M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Kim in the interactive graph →